Reed Elsevier NV (ADR)  

(Public, NYSE:ENL)   Watch this stock  
Find more results for ENL
-0.70 (-1.40%)
Apr 17 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 49.11 - 49.64
52 week 40.51 - 51.81
Open 49.61
Vol / Avg. 53,656.00/99,434.00
Mkt cap 17.16B
P/E 27.35
Div/yield 0.98/2.79
EPS 1.81
Shares 650.52M
Beta 1.18
Inst. own 1%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 17.20% 16.62%
Operating margin 24.09% 24.28%
EBITD margin - 29.14%
Return on average assets 47.33% 40.82%
Return on average equity 49.32% 42.39%
CDP Score - -


Radarweg 29
+31-20-4852222 (Phone)
+31-20-4852032 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Reed Elsevier NV is a Netherlands-based company holding shares in RELX Group plc. RELX Group plc is a global provider of information solutions for professional customers across industries. The Company operates in four market segments: Scientific, Technical & Medical, providing information and tools to help customers improve scientific and healthcare outcomes; Risk and Business Information, providing data services and tools that combine proprietary, public and third-party information with technology and analytics to business and government customers; Legal, providing legal, regulatory, and news & business information to law firms and to corporate, government and academic customers; and Exhibitions, organizing exhibitions and conferences. External shareholders in Reed Elsevier NV own a 47.1% economic interest in RELX Group plc.

Officers and directors

Erik Engstrom Chief Executive Officer, Executive Director
Age: 51
Bio & Compensation  - Reuters
Nick L. Luff Chief Financial Officer, Executive Director
Age: 47
Bio & Compensation  - Reuters
Mark Kelsey Chief Executive Officer Risk Solutions and Business Information
Bio & Compensation  - Reuters
Ron Mobed Chief Executive Officer Scientific, Technical & Medical
Age: 55
Bio & Compensation  - Reuters
Mike Rusbridge Chief Executive Officer Exhibitions
Bio & Compensation  - Reuters
Mike Walsh Chief Executive Officer Legal
Bio & Compensation  - Reuters
Henry Udow Chief Legal Officer and Company Secretary
Bio & Compensation  - Reuters
Ian Fraser Human Resources Director
Bio & Compensation  - Reuters
Kumsal Bayazit Chief Strategy Officer
Bio & Compensation  - Reuters
Youngsuk Chi Director of Corporate Affairs and Chairman Elsevier
Bio & Compensation  - Reuters